Hexachlorophane for treating carriers of Staphylococcus aureus.
D002353:Carrier State / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D006582:Hexachlorophene / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009666:Nose; D009824:Ointments; D010403:Penicillin Resistance; D011511:Proteus / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013203:Staphylococcal Infections; D013210:Staphylococcus / Q000302:isolation & purification
D009824:Ointments; D006582:Hexachlorophene